Heights Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
BBA
Heights Capital Management's ALT Position: Q4 2020 in Review
Heights Capital Management sold out of Altimmune (ALT) in Q4 2020, closing a stake of 10,600 shares — an estimated $140K sold.
Heights Capital Management first reported a position in ALT in Q3 2018 and held it in 3 quarters. The position peaked at $408K in Q3 2018. 89 funds tracked by Wall St. Rank hold ALT as of Q4 2020.
- Heights Capital Management reported no remaining Altimmune position as of Q4 2020 after selling out during the quarter.
- Heights Capital Management sold 10,600 Altimmune shares in Q4 2020, an estimated $140K.
- Heights Capital Management first reported a position in Altimmune in Q3 2018 and held it in 3 quarters.
- Heights Capital Management's Altimmune position peaked at $408K in Q3 2018.
- 89 funds tracked by Wall St. Rank held Altimmune as of Q4 2020.
Based on Heights Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.